These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interferon and other antiviral agents, with special reference to influenza: a memorandum. Bull World Health Organ; 1978; 56(2):229-40. PubMed ID: 307453 [TBL] [Abstract][Full Text] [Related]
3. Biological assays for interferons. Meager A J Immunol Methods; 2002 Mar; 261(1-2):21-36. PubMed ID: 11861063 [TBL] [Abstract][Full Text] [Related]
4. Standardization of human IFN gamma in comparison with other interferons. Meager A Lymphokine Res; 1986; 5 Suppl 1():S111-4. PubMed ID: 2431231 [No Abstract] [Full Text] [Related]
6. Differentiation of types of interferon by kinetics of development of the antiviral state. Dianzani F; Baron S Methods Enzymol; 1981; 78(Pt A):409-14. PubMed ID: 6173622 [No Abstract] [Full Text] [Related]
7. Establishment of new and replacement World Health Organization International Biological Standards for human interferon alpha and omega. Meager A; Gaines Das R; Zoon K; Mire-Sluis A J Immunol Methods; 2001 Nov; 257(1-2):17-33. PubMed ID: 11687235 [TBL] [Abstract][Full Text] [Related]
8. Comparison of three bioassays for rat interferon. Burleson GR; Herzog DP J Virol Methods; 1984 Oct; 9(2):163-71. PubMed ID: 6210298 [TBL] [Abstract][Full Text] [Related]
9. Characterisation, calibration and comparison by international collaborative study of international standards for the calibration of therapeutic preparations of FSH. Rose MP; Gaines-Das RE J Endocrinol; 1998 Jul; 158(1):97-114. PubMed ID: 9713331 [TBL] [Abstract][Full Text] [Related]
10. Interferon assay anomaly variation of interferon response with cell type and sialic acid content. Schwartz AA; Villani-Price D Adv Exp Med Biol; 1978; 110():153-7. PubMed ID: 727039 [TBL] [Abstract][Full Text] [Related]
14. Biological standardization of cytokines. Meager A Dev Biol Stand; 1988; 69():199-206. PubMed ID: 2465195 [TBL] [Abstract][Full Text] [Related]
15. A convenient and rapid cytopathic effect inhibition assay for interferon. Familletti PC; Rubinstein S; Pestka S Methods Enzymol; 1981; 78(Pt A):387-94. PubMed ID: 6173617 [No Abstract] [Full Text] [Related]
16. The impossibility of defining unequivocally the antiviral activity of human fibroblast interferon in terms of a human leukocyte interferon standard. Hilfenhaus F J Biol Stand; 1978; 6(2):159-64. PubMed ID: 649623 [No Abstract] [Full Text] [Related]
17. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. Rubin BY; Gupta SL Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5928-32. PubMed ID: 6160587 [TBL] [Abstract][Full Text] [Related]
18. [Method of increasing the activity of a preparation of human cadaver leukocyte interferon]. Parfenov VV; Zubanova NA; Mekhedov LN; Pokidysheva LN; Kuznetsov VP Vopr Virusol; 1980; (3):294-7. PubMed ID: 6159731 [TBL] [Abstract][Full Text] [Related]
19. Multiple active sites on human interferons. Paucker K; Dalton BJ; Ogburn CA; Törmä E Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4587-91. PubMed ID: 53841 [TBL] [Abstract][Full Text] [Related]
20. Interferon. Ho M; Armstrong JA Annu Rev Microbiol; 1975; 29():131-61. PubMed ID: 1180510 [No Abstract] [Full Text] [Related] [Next] [New Search]